Expression of amphiregulin in mucoepidermoid carcinoma of the major salivary glands: a molecular and clinicopathological study
Open Access
- 1 November 2016
- journal article
- research article
- Published by Elsevier in Human Pathology
- Vol. 57, 37-44
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Aberrantly activated AREG–EGFR signaling is required for the growth and survival of CRTC1–MAML2 fusion-positive mucoepidermoid carcinoma cellsOncogene, 2013
- HER2 and EGFR gene copy number alterations are predominant in high‐grade salivary mucoepidermoid carcinoma irrespective of MAML2 fusion statusHistopathology, 2013
- Immunohistochemistry-based Cell Cycle Detection (iCCD)American Journal of Surgical Pathology, 2012
- Impact of CRTC1/3-MAML2 fusions on histological classification and prognosis of mucoepidermoid carcinomaHistopathology, 2011
- Activation of the EGFR/ERK pathway in high-grade mucoepidermoid carcinomas of the salivary glandsBritish Journal of Cancer, 2010
- Clinicopathological significance of the CRTC3–MAML2 fusion transcript in mucoepidermoid carcinomaLaboratory Investigation, 2009
- An Update on Grading of Salivary Gland CarcinomasHead and Neck Pathology, 2009
- Autocrine Production of Amphiregulin Predicts Sensitivity to Both Gefitinib and Cetuximab in EGFR Wild-type CancersClinical Cancer Research, 2008
- CRTC1/MAML2 fusion transcript in high grade mucoepidermoid carcinomas of salivary and thyroid glands and Warthin's tumors: Implications for histogenesis and biologic behaviorGenes, Chromosomes and Cancer, 2007
- t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathwayNature Genetics, 2003